- 4-Week # shares sold: 118
- 12-Week # shares sold: 118
- 24-Week # shares sold: 5,118
Siggi Olfasson is poised to step down as president and CEO of Teva's global generic medicines group by the end the first quarter of 2017.
Hillary isn't the only one who seems to favor workers over capital. Trump does, too.